Global Blood Serum Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Blood Serum Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Market Overview:

The latest research study on the global Blood Serum market finds that the global Blood Serum market reached a value of USD 1284.52 million in 2022. It’s expected that the market will achieve USD 1823.15 million by 2028, exhibiting a CAGR of 6.01% during the forecast period.

Influence of COVID-19 Outbreak on Blood Serum Industry Development

The explosive growth of COVID-19 has had a huge impact on the blood serum industry.

On the one hand, after the outbreak of COVID-19, for all countries or pharmaceutical and biotechnology companies, developing vaccines or drugs for COVID-19 has become the focus of current development. Blood serum plays a key role in both vaccine and drug development. Before conducting human experiments, many companies use blood serum experiments to verify the effectiveness of vaccines or drugs developed.

On the other hand, due to the impact of COVID-19, many countries have adopted strict blockade measures, which have caused great damage to the industrial and supply chains of many industries. For the blood serum industry, the epidemic of COVID-19 will affect logistics and transportation, thereby affecting the collection and storage of blood serum. At the same time, due to the epidemic, the demand for blood serum has increased, but the supply chain has been hit, and the country's prudent regulatory policies for blood serum products have made the supply of blood serum insufficient.

Market Driver Analysis

Whether in small-scale research applications or large-scale industrial production, blood serum plays a vital role in successful cell culture. Blood serum is a highly complex organic solution that contains a variety of cellular components, including vitamins, nutrients, nucleosides, amino acids, carbohydrates, hormones, etc. Serum not only provides essential nutrients for cells, but also promotes most or all cell functions, such as mitosis, attachment and proliferation, necessary for healthy cell culture. With the continuous development of the biopharmaceutical industry, the use of blood serum in vaccine production, drug discovery and toxicity testing promotes the demand for blood serum, thereby promoting the steady growth of the blood serum industry.

Market Restraints Analysis

The current blood serum is mainly derived from cattle, horses and pigs. There are usually special donor farms to provide blood serum, and the industry is loosely regulated in terms of animal welfare. Take horse blood serum as an example. Usually, a horse is injected with a disease and develops immunity, and then the doctor draws the blood of the immunized horse and uses the serum to create a vaccine against humans. Horses that are usually used to donate blood do not use many vaccines so that the blood of these horses is considered purer. Among them, a hormone produced by pregnant mares, serum gonadotropin (PMSG), has attracted special attention from animal rights organizations in recent years. PMSG is used in the manufacture of drugs for the animal industry, and the biggest use is in the pig production industry. However, the main problem in PMSG production is the welfare of mares and babies. In most cases, a mare will have a miscarriage during pregnancy. If the foals are brought to full term, they may be slaughtered, or have the same purpose as the mother. In order to obtain PMSG, a mare may have to go through the process of pregnancy, blood donation, and abortion. With the increase in awareness of animal protection, animal rights organizations have begun to call for the protection of the welfare of these donor horses. At present, Europe and other regions have begun to call for the complete cessation of PMSG production. Increased awareness of animal protection will re-examine the means and motivations of the animal blood donation industry, and drive the improvement of the animal blood donation industry. At the same time, the supply of blood serum will also be restricted, thus limiting the development of the blood serum industry.

Region Overview:

North America had the highest growth rate of all regions.

Company Overview

Thermo Fisher (Life-Tech) is one of the major players operating in the Blood Serum market, holding a share of 9.55% in 2020.

Thermo Fisher (Life-Tech) offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.

Cytiva (formerly GE Healthcare Life Sciences) is a company that provides technologies and services to support the development and manufacture of therapeutics. It offers a range of products with a focus on bioprocess filtration, cell therapy, molecular biology, liquid preparation and management, protein analysis, and other related areas. In addition, the company provides scientific support, training, and bio-manufacturing services.

Segmentation Overview:

Among different product types, Bovine (Fetal Bovine, Newborn Calf, Calf, Adult Bovine) segment is anticipated to contribute the largest market share in 2027.

Application Overview:

By application, the Cell culture media segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Blood Serum market covered in Chapter 3:

VWR
Bio-Techne
Wuhan Sanli
Bovogen
Lanzhou Minhai
South Pacific Sera
Zhejiang Tianhang
Moregate Biotech
Cytiva
Jin Yuan Kang
Bioind
Thermo Fisher (Life-Tech)
Gemini Bio
Merck Group
Corning

In Chapter 4 and Chapter 14.2, on the basis of types, the Blood Serum market from 2018 to 2029 is primarily split into:

Bovine (Fetal Bovine, Newborn Calf, Calf, Adult Bovine)
Equine
Porcine
Other

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Blood Serum market from 2018 to 2029 covers:

Cell culture media
Cell line saving
Tissue culture
Diagnostic reagents

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)